Lessons From Generic Launches: About The Study
Executive Summary
IMS Consulting Group studied 4,564 generic launches dating between July 1, 2005 and July 31, 2010, in order to gauge key criteria for success.
You may also be interested in...
Entering The Generics Business In Mature Markets: Lessons Learned From 4,500 Launches
In response to major market challenges, Big Pharmas have or are considering entering the small-molecule generics business. An IMS Consulting Group analysis of more than 4,500 generics launches between 2005 and 2010 tracks key attributes would-be branded company players need to know for success.
Recordati's OTC Sales Growing Double-Digits Thanks to Post-Pandemic Rebound
Returning demand for cough & cold products and nasal sprays has lifted Recordati's OTC sales by 14% in the first nine months of 2022.
Human Factors Guidance Provides Clarity On Data Necessary In Premarket Submissions
FDA released an updated human factors guidance document on 9 December clarifying the types of human factor data the agency wants to see in pre-market submissions.